Fidelity Investments
CRVO icon

Fidelity Investments’s CervoMed CRVO Stock Holding History

Fidelity Investments’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.7K Sell
10,538
-502
-5% -$1.77K ﹤0.01% 4484
2026
Q1 		$43.5K Sell
11,040
-286
-3% -$1.49K ﹤0.01% 4189
2025
Q4 		$89.5K Sell
11,326
-211
-2% -$1.7K ﹤0.01% 3816
2025
Q3 		$93.3K Sell
11,537
-500
-4% -$4.29K ﹤0.01% 3695
2025
Q2 		$75.7K Buy
12,037
+382
+3% +$3.25K ﹤0.01% 3722
2025
Q1 		$107K Buy
11,655
+10,603
+1,008% +$40.4K ﹤0.01% 3527
2024
Q4 		$2.46K Sell
1,052
-2,811
-73% -$27.3K ﹤0.01% 4790
2024
Q3 		$56.4K Buy
+3,863
New +$59.9K ﹤0.01% 3732
2021
Q3 		– Hold
0
– – – 4428
2021
Q2 		– Hold
0
– – – 4325

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Fidelity Investments's CRVO Position: Q2 2026 in Review

Fidelity Investments reduced its CervoMed (CRVO) stake by 4.5% in Q2 2026, selling an estimated $1.77K and leaving 10,538 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4484.

Fidelity Investments first reported a position in CRVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $107K in Q1 2025. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Fidelity Investments held 10,538 shares of CervoMed worth $32.7K as of Q2 2026.
  • Fidelity Investments sold 502 CervoMed shares in Q2 2026, an estimated $1.77K.
  • CervoMed made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4484 holding.
  • Fidelity Investments first reported a position in CervoMed in Q3 2024 and has held it in 8 quarters since.
  • Fidelity Investments's CervoMed position peaked at $107K in Q1 2025.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.